Recruitment to clinical trials, except COVID-19 trials, are currently on hold due to the COVID-19 outbreak.

The Myeloma Trial Finder lists clinical trials which are currently recruiting in the UK. If you are thinking about joining a clinical trial you should talk to your healthcare team to find out if this is a suitable option for you.

It provides information about clinical trials in the UK. Trials included are not necessarily endorsed by Myeloma UK.

Further information can be found on our website under Clinical Trials and Novel Drugs or if you would like to speak to someone please call the Myeloma UK infoline on 0800 980 3332

There are currently 20 open trials. In 106 locations

What is a Clinical Trial?

Step 2: Choose a Trial

There are currently 20 open trials

Step 3: View Details

Trial Title:

A comparison of imaging techniques used to visualise myeloma in the bone marrow


Myeloma stage:

Trial phase:



This study will compare two different imaging methods (PET/MRI scan or PET/CT scan). It aims to determine which method is the best way to see where myeloma is most active in newly diagnosed myeloma patients.



King's College Hospital, London

Who can enter the study?

Who can enter the study?:

Newly diagnosed myeloma patients who will receive HDT-SCT as their initial treatment.

What's involved?

What's involved?:

Participants will be assessed and treated as usual, except that they will have an additional scan, a PET/MRI scan, as well as each standard PET/CT scan so that the two imaging methods can be compared. The scans will be done before treatment and after induction treatment (anti-myeloma treatment) given to patients before high-dose therapy and stem cell transplantation (HDT-SCT).

Clinical Information

Clinical Information
(for Medical Professionals):

This study will compare PET/MRI with PET/CT, in patients with myeloma who will be treated with HDT-SCT.

For more information, click here.


Find out more about Myeloma UK:


Do you want to talk to someone? Call our myeloma Infoline